Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A05255 | 33321448 | Complement Ther Clin Pract | Efficacy of resveratrol supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials. | 2020 | Details |
| A05256 | 33321020 | Acta Gastroenterol Belg | Proteins involved in lipid metabolism as possible biomarkers or predisposing factors for non-alcoholic fatty liver disease. | 2020 | Details |
| A05257 | 33321012 | Acta Gastroenterol Belg | Microvesicular steatosis: a missed item in the management of nonalcoholic fatty liver disease? | 2020 | Details |
| A05258 | 33321011 | Acta Gastroenterol Belg | The changing pattern of cirrhosis in Belgium: a study based on two cohorts prospectively collected 15 years apart. | 2020 | Details |
| A05260 | 33320545 | ACS Biomater Sci Eng | Modeling Human Nonalcoholic Fatty Liver Disease (NAFLD) with an Organoids-on-a-Chip System. | 2020 | Details |
| A05261 | 33320482 | Postepy Biochem | Transcription factor ChREBP – the coordinator of carbohydrate and lipid metabolism | 2020 | Details |
| A05262 | 33320268 | J Infect Dis | Increased Prevalence of Liver Fibrosis in People Living With Human Immunodeficiency Virus Without Viral Hepatitis Compared to Population Controls. | 2021 | Details |
| A05263 | 33320193 | Endocrinology | The Importance of Keeping Time in the Liver. | 2021 | Details |
| A05264 | 33320023 | Drug Dev Ind Pharm | Optimized preparation of eugenol microcapsules and its effect on hepatic steatosis in HepG2 cells. | 2020 | Details |
| A05265 | 33319629 | Drug Chem Toxicol | Effects of Rhus coriaria L. hydroalcoholic extract on the lipid and antioxidant profile in high fat diet-induced hepatic steatosis in rats. | 2018 | Details |
| A05266 | 33319459 | Liver Int | Metabolic-associated fatty liver disease (MAFLD) in coeliac disease. | 2020 | Details |
| A05267 | 33319051 | JGH Open | Use of simple scoring systems for a public health approach in the management of non-alcoholic fatty liver disease patients. | 2020 | Details |
| A05268 | 33318872 | J Adv Res | Implications of hydrogen sulfide in liver pathophysiology: Mechanistic insights and therapeutic potential. | 2020 | Details |
| A05269 | 33318628 | Cell Mol Immunol | Gut microbiome, liver immunology, and liver diseases. | 2020 | Details |
| A05270 | 33318479 | Cell Death Dis | Phosphorylation of eIF2α signaling pathway attenuates obesity-induced non-alcoholic fatty liver disease in an ER stress and autophagy-dependent manner. | 2020 | Details |
| A05272 | 33317575 | Lipids Health Dis | A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet. | 2020 | Details |
| A05273 | 33317254 | Clin Mol Hepatol | Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis. | 2020 | Details |
| A05274 | 33317243 | Clin Mol Hepatol | Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease. | 2020 | Details |
| A05276 | 33317065 | Biomedicines | Dietary-Induced Low-Grade Inflammation in the Liver. | 2020 | Details |
| A05277 | 33316927 | Int J Mol Sci | Unraveling the Role of Leptin in Liver Function and Its Relationship with Liver Diseases. | 2020 | Details |
| A05278 | 33315911 | PLoS One | The antihypertensive agent hydralazine reduced extracellular matrix synthesis and liver fibrosis in nonalcoholic steatohepatitis exacerbated by hypertension. | 2020 | Details |
| A05279 | 33314991 | Metab Syndr Relat Disord | Association of the Serum Uric Acid-to-Creatinine Ratio with Nonalcoholic Fatty Liver Disease Diagnosed by Computed Tomography. | 2020 | Details |
| A05280 | 33314233 | Med J Aust | Australian recommendations for the management of hepatocellular carcinoma: a consensus statement. | 2020 | Details |
| A05281 | 33313159 | Ann Transl Med | Development of a simple nonalcoholic fatty liver disease scoring system indicative of metabolic risks and insulin resistance. | 2020 | Details |
| A05282 | 33313020 | Can J Gastroenterol Hepatol | Acute Coronary Syndromes and Nonalcoholic Fatty Liver Disease: "Un Affaire de Coeur". | 2020 | Details |
| A05283 | 33312933 | Health Promot Perspect | Effects of oleoylethanolamide supplementation on atherogenic indices and hematological parameters in patients with nonalcoholic fatty liver disease: A clinical trial. | 2020 | Details |
| A05284 | 33312845 | Curr Treat Options Pediatr | When the beverage is sweet, how does the liver feel? | 2019 | Details |
| A05285 | 33312425 | World J Hepatol | Phase angle and non-alcoholic fatty liver disease before and after bariatric surgery. | 2020 | Details |
| A05286 | 33312424 | World J Hepatol | Cannabis use history is associated with increased prevalence of ascites among patients with nonalcoholic fatty liver disease: A nationwide analysis. | 2020 | Details |
| A05287 | 33312420 | World J Hepatol | Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo. | 2020 | Details |
| A05288 | 33311949 | World J Gastroenterol | Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndrome. | 2020 | Details |
| A05289 | 33311939 | World J Gastroenterol | Pituitary stalk interruption syndrome and liver changes: From clinical features to mechanisms. | 2020 | Details |
| A05290 | 33311892 | J Clin Exp Hepatol | Telemedicine Improves Access to Hepatology Consultation with High Patient Satisfaction. | 2020 | Details |
| A05291 | 33310947 | Wiad Lek | CORRECTION OF AUTONOMIC AND COGNITIVE DISTURBANCES IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE. | 2020 | Details |
| A05292 | 33310266 | Diabetes Metab Syndr | Performance of serum CD163 as a marker of fibrosis in patients with NAFLD. | 2020 | Details |
| A05293 | 33310185 | Biochem Biophys Res Commun | Impaired CCR9/CCL25 signalling induced by inefficient dendritic cells contributes to intestinal immune imbalance in nonalcoholic steatohepatitis. | 2020 | Details |
| A05294 | 33310034 | Life Sci | Aerobic training improves NAFLD markers and insulin resistance through AMPK-PPAR-α signaling in obese mice. | 2020 | Details |
| A05295 | 33309929 | J Proteomics | Proteome and phosphoproteome characterization of liver in the postprandial state from diet-induced obese and lean mice. | 2020 | Details |
| A05296 | 33309568 | HPB (Oxford) | Clinical and survival outcomes after hepatectomy in patients with non-alcoholic fatty liver and hepatitis B-related hepatocellular carcinoma. | 2020 | Details |
| A05297 | 33309563 | Clin Res Hepatol Gastroenterol | Liraglutide in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. | 2020 | Details |
| A05298 | 33309070 | Clin Investig Arterioscler | Approach to the cardiometabolic continuum. Narrative description. | 2020 | Details |
| A05299 | 33309037 | Am J Surg | The impact of bariatric surgery on nonalcoholic fatty liver disease as measured using non-invasive tests. | 2020 | Details |
| A05302 | 33308253 | J Transl Med | Circular RNA expression profiles and features in NAFLD mice: a study using RNA-seq data. | 2020 | Details |
| A05303 | 33308192 | BMC Complement Med Ther | Hugan Qingzhi medication ameliorates free fatty acid-induced L02 hepatocyte endoplasmic reticulum stress by regulating the activation of PKC-δ. | 2020 | Details |
| A05304 | 33308101 | Am J Chin Med | Antrodia Cinnamomea Attenuates Non-Alcoholic Steatohepatitis by Suppressing NLRP3 Inflammasome Activation In Vitro and In Vivo. | 2020 | Details |
| A05305 | 33307138 | J Hepatol | Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease. | 2020 | Details |
| A05306 | 33307033 | Gastroenterology | The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis. | 2020 | Details |
| A05307 | 33307021 | Gastroenterology | AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review. | 2020 | Details |
| A05308 | 33306695 | PLoS One | Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease. | 2020 | Details |
| A05309 | 33306682 | PLoS One | Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH). | 2020 | Details |
| A05310 | 33306598 | J Chin Med Assoc | Interleukin-2 receptor alpha as a biomarker for nonalcoholic fatty liver disease diagnosis. | 2021 | Details |
| A05311 | 33306506 | Am J Gastroenterol | Impact of the Association Between PNPLA3 Genetic Variation and Dietary Intake on the Risk of Significant Fibrosis in Patients With NAFLD. | 2021 | Details |
| A05312 | 33305889 | Pediatr Obes | The relationship between excessive dietary fructose consumption and paediatric fatty liver disease. | 2020 | Details |
| A05313 | 33305150 | Hepatol Commun | Elevated Glycated Hemoglobin Is Associated With Liver Fibrosis, as Assessed by Elastography, in a Population-Based Study of Mexican Americans. | 2020 | Details |
| A05314 | 33305148 | Hepatol Commun | The Growing Burden of Disability Related to Nonalcoholic Fatty Liver Disease: Data From the Global Burden of Disease 2007-2017. | 2020 | Details |
| A05315 | 33304627 | Curr Health Sci J | The Role of Elastography in Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A05316 | 33304027 | Toxicol Environ Chem | Per- and Polyfluoroalkyl Substances and Obesity, Type 2 Diabetes and Non-alcoholic Fatty Liver Disease: A Review of Epidemiologic Findings. | 2020 | Details |
| A05317 | 33303988 | Acta Pharmacol Sin | 3,4-dihydroxytoluene, a metabolite of rutin, suppresses the progression of nonalcoholic fatty liver disease in mice by inhibiting p300 histone acetyltransferase activity. | 2020 | Details |
| A05318 | 33303970 | Lab Invest | Stress can attenuate hepatic lipid accumulation via elevation of hepatic β-muricholic acid levels in mice with nonalcoholic steatohepatitis. | 2020 | Details |
| A05319 | 33303715 | Ann Lab Med | Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases. | 2021 | Details |
| A05320 | 33303638 | Diabetes Care | High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes. | 2020 | Details |
| A05321 | 33303564 | Gut | Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis. | 2020 | Details |
| A05322 | 33302841 | Curr Hypertens Rev | Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the Liver. | 2021 | Details |
| A05323 | 33302736 | Exp Biol Med (Maywood) | Characterizing disease progression of nonalcoholic steatohepatitis in Leptin-deficient rats by integrated transcriptome analysis. | 2020 | Details |
| A05324 | 33302643 | Ann Palliat Med | Computer-assisted ultrasound quantification analysis in fatty liver model of rats. | 2020 | Details |
| A05325 | 33302598 | Int J Mol Sci | Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice. | 2020 | Details |
| A05326 | 33302316 | Horm Metab Res | Acute Elevated Resistin Exacerbates Mitochondrial Damage and Aggravates Liver Steatosis Through AMPK/PGC-1α Signaling Pathway in Male NAFLD Mice. | 2020 | Details |
| A05327 | 33301513 | PLoS One | RYGB increases postprandial gastric nesfatin-1 and rapid relieves NAFLD via gastric nerve detachment. | 2020 | Details |
| A05328 | 33301423 | J Clin Invest | Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis. | 2021 | Details |
| A05329 | 33300526 | Food Funct | Improvement of the hepatic lipid status in intrauterine growth retarded pigs by resveratrol is related to the inhibition of mitochondrial dysfunction, oxidative stress and inflammation. | 2020 | Details |
| A05330 | 33300483 | Cardiol Young | Three-dimensional speckle tracking echocardiography for early detection of left ventricular dysfunction in children with non-alcoholic fatty liver diseases. | 2020 | Details |
| A05331 | 33299871 | Biomed Res Int | Protective Role of Probiotic Supplements in Hepatic Steatosis: A Rat Model Study. | 2020 | Details |
| A05332 | 33299856 | Biomed Res Int | GCN2 Deficiency Enhances Protective Effects of Exercise on Hepatic Steatosis. | 2020 | Details |
| A05334 | 33299110 | Mod Pathol | A large-scale internal validation study of unsupervised virtual trichrome staining technologies on nonalcoholic steatohepatitis liver biopsies. | 2020 | Details |
| A05336 | 33298885 | Cell Death Dis | Hepatocyte cannabinoid 1 receptor nullification alleviates toxin-induced liver damage via NF-κB signaling. | 2020 | Details |
| A05337 | 33298075 | Lipids Health Dis | Hepatic lipid profile in mice fed a choline-deficient, low-methionine diet resembles human non-alcoholic fatty liver disease. | 2020 | Details |
| A05338 | 33297922 | CNS Neurol Disord Drug Targets | Liver-Brain Axis in Sporadic Alzheimer's Disease: Role of Ten Signature Genes in a Mouse Model. | 2021 | Details |
| A05339 | 33296951 | Pediatr Obes | A Prudent dietary pattern is inversely associated with liver fat content among multi-ethnic youth. | 2020 | Details |
| A05340 | 33296704 | Diabetes Metab | NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment. | 2020 | Details |
| A05341 | 33296678 | Cell Metab | Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05342 | 33294831 | JHEP Rep | Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease. | 2020 | Details |
| A05343 | 33294458 | Biomed Res Int | APOC3 rs2070667 Associates with Serum Triglyceride Profile and Hepatic Inflammation in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05344 | 33293992 | Evid Based Complement Alternat Med | Effect of Sheng-Jiang Powder on Gut Microbiota in High-Fat Diet-Induced NAFLD. | 2020 | Details |
| A05345 | 33293347 | Diabetes Care | Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05346 | 33292701 | Biomark Res | Dysregulated bile acid receptor-mediated signaling and IL-17A induction are implicated in diet-associated hepatic health and cognitive function. | 2020 | Details |
| A05347 | 33291863 | Clin Mol Hepatol | The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease. | 2020 | Details |
| A05348 | 33291552 | Children (Basel) | Glutamate-Serine-Glycine Index: A Novel Potential Biomarker in Pediatric Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A05349 | 33291177 | Z Gastroenterol | [Liver-specific diagnostic for non-alcoholic fatty liver disease (NAFLD) - time to replace liver biopsy?] | 2020 | Details |
| A05350 | 33290237 | Diagn Interv Radiol | MRI quantification techniques in fatty liver: the diagnostic performance of hepatic T1, T2, and stiffness measurements in relation to the proton density fat fraction. | 2021 | Details |
| A05351 | 33290156 | Can J Physiol Pharmacol | Theobromine ameliorates nonalcoholic fatty liver disease by regulating hepatic lipid metabolism via mTOR signaling pathway in vivo and in vitro. | 2020 | Details |
| A05352 | 33289350 | Diabetes Obes Metab | Inhibition of fatty acid synthase with FT-4101 safely reduces hepatic de novo lipogenesis and steatosis in obese subjects with non-alcoholic fatty liver disease: Results from two early-phase randomized trials. | 2020 | Details |
| A05353 | 33289147 | J Food Biochem | A high-fructose diet in rats induces systemic iron deficiency and hepatic iron overload by an inflammation mechanism. | 2020 | Details |
| A05354 | 33285128 | Am J Med | Life's Simple 7 and Nonalcoholic Fatty Liver Disease: The Multiethnic Study of Atherosclerosis. | 2020 | Details |
| A05355 | 33284502 | Hepatology | Metabolic Landscape of the Mouse Liver by Quantitative 31 P Nuclear Magnetic Resonance Analysis of the Phosphorome. | 2021 | Details |
| A05356 | 33284184 | Am J Gastroenterol | Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel Recommendations. | 2021 | Details |
| A05357 | 33283879 | J Cell Physiol | Endogenous metabolite, kynurenic acid, attenuates nonalcoholic fatty liver disease via AMPK/autophagy- and AMPK/ORP150-mediated signaling. | 2020 | Details |
| A05358 | 33283415 | Liver Int | Fibrosis progression rate in a systematic review of placebo-treated nonalcoholic steatohepatitis. | 2020 | Details |
| A05360 | 33282902 | Front Nutr | Maternal High-Fat Diet Leads to Non-alcoholic Fatty Liver Disease Through Upregulating Hepatic SCD1 Expression in Neonate Rats. | 2020 | Details |
| A05361 | 33282899 | Front Nutr | Corrigendum: PTEN: A Thrifty Gene That Causes Disease in Times of Plenty? | 2020 | Details |
| A05362 | 33282271 | Food Sci Nutr | Protective effect of celastrol on type 2 diabetes mellitus with nonalcoholic fatty liver disease in mice. | 2020 | Details |